A systematic review of validated methods for identifying transfusion-related sepsis using administrative and claims data
Version of Record online: 19 JAN 2012
Copyright © 2012 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Supplement: The U.S. Food and Drug Administration's Mini-Sentinel Program
Volume 21, Issue Supplement S1, pages 222–229, January 2012
How to Cite
Carnahan, R. M., Herman, R. A. and Moores, K. G. (2012), A systematic review of validated methods for identifying transfusion-related sepsis using administrative and claims data. Pharmacoepidem. Drug Safe., 21: 222–229. doi: 10.1002/pds.2322
- Issue online: 19 JAN 2012
- Version of Record online: 19 JAN 2012
- Food and Drug Administration (FDA). Grant Number: HHSF223200910006I
- 5The ICD-9 code for septicemia maintains a high positive predictive value for clinical sepsis. Am J Respir Crit Care Med 2002; 165: A471., , , .
- 11Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644–1655., , , et al.
- 12Version 4.1 technical documentation AHRQ Quality Indicators. December, 2009. Agency for Healthcare Research and Quality, Rockville, MD. http://www.qualityindicators.ahrq.gov/TechnicalSpecs41.htm [accessed 24 August, 2010].
- 13Proposed changes to ICD-9-CM: transfusion associated adverse events. Presented September 17, 2009, at the ICD-9-CM Coordination and Maintenance Committee Meeting. http://www.cdc.gov/nchs/ppt/icd9/att1_Menis_Sep09.pdf [accessed 1 September, 2010]..
- 14Department of Health and Human Services, Centers for Medicare & Medicaid Services. Medicare Program; Pub 100–04 Medicare Claims Processing, June 24, 2011. https://www.cms.gov/transmittals/downloads/R2246CP.pdf [accessed 9 September, 2011].